The sweet taste receptor, TAS1R2-TAS1R3, plays a dual role in regulating glucose metabolism. Stimulating this receptor with sucralose accelerates insulin release, while inhibiting it with lactisole slows insulin release. This finding suggests that targeting TAS1R2-TAS1R3 could offer new therapeutic avenues for managing metabolic disorders like diabetes.
The sweet taste receptor, TAS1R2-TAS1R3, plays a dual role in regulating glucose metabolism. Stimulating this receptor with sucralose accelerates insulin release, while inhibiting it with lactisole slows insulin release. This finding suggests that targeting TAS1R2-TAS1R3 could offer new therapeutic avenues for managing metabolic disorders like diabetes.
Share this Article
Recommended